OVV250117P42000
- 0.05
- -0.19-79.17%
Ovintiv Newsroom
BofA Upgrades Ovintiv to Buy From Neutral, Trims Price Target to $54 From $55
Truist Financial Maintains Ovintiv(OVV.US) With Buy Rating, Announces Target Price $60
Ovintiv Analyst Ratings
BofA Securities Upgrades Ovintiv(OVV.US) to Buy Rating, Cuts Target Price to $54
Barclays Maintains Ovintiv(OVV.US) With Buy Rating, Maintains Target Price $57
Wolfe Research Maintains Ovintiv(OVV.US) With Buy Rating, Raises Target Price to $70
Wells Fargo Maintains Ovintiv(OVV.US) With Hold Rating, Cuts Target Price to $42
Ovintiv Is Maintained at Outperform by Mizuho
Mizuho Securities Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $60
Ovintiv Analyst Ratings
UBS Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $56
J.P. Morgan Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $51
Citi Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $54
J.P. Morgan Sticks to Their Buy Rating for Ovintiv (OVV)
Wells Fargo Maintains Ovintiv(OVV.US) With Hold Rating, Maintains Target Price $48
UBS Maintains Ovintiv(OVV.US) With Buy Rating, Raises Target Price to $59
Scotiabank Maintains Ovintiv(OVV.US) With Buy Rating, Raises Target Price to $53
Ovintiv Analyst Ratings
Ovintiv (OVV) Gets a Hold From RBC Capital
Mizuho Securities Maintains Ovintiv(OVV.US) With Buy Rating, Raises Target Price to $63